EMR vs OTIS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 03, 2026

EMR

54.9
AI Score
VS
EMR Wins

OTIS

45.7
AI Score

Investment Advisor Scores

EMR

Aug 03, 2026
55score
Recommendation
HOLD

OTIS

Aug 03, 2026
46score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric EMR OTIS Winner
Forward P/E 20.3252 18.0832 OTIS
PEG Ratio 2.0325 1.4444 OTIS
Revenue Growth 2.9% 7.3% OTIS
Earnings Growth 27.9% 13.0% EMR
Tradestie Score 54.9/100 45.7/100 EMR
Profit Margin 13.4% 10.2% EMR
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

EMR 1M: +10.9% · 3M: +12.2% OTIS 1M: -1.1% · 3M: -6.1%

Current Technical Phase

EMR

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.2% over 20 days), RSI 65

RSI (14): 65.3 · Price: $154.20

OTIS

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -1.4%) with fading momentum, RSI 49

RSI (14): 49.3 · Price: $72.35

Fundamentals Snapshot

Metric EMR OTIS
Market Cap
Forward P/E 20.9 15.6
Trailing P/E 33.8 18.4
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.5% 0.3%
Operating Margin 0.2% 0.2%
EPS 4.40 3.89
Dividend Yield 0.01% 0.02%

Frequently Asked Questions

Based on our detailed analysis, EMR is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.